Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HDLIPIDS2011

Financiado

Cerrado

Role of sphingolipids in white matter dysfunction in Huntington s disease

Huntington’s disease (HD) is a neurodegenerative disorder caused by expansion of a CAG repeat, within the gene encoding huntingtin (Htt) and characterized by the progressive neurodegeneration and associated motor, cognitive and be... ver más

09/06/2015

INSTITUTO NEUROLOG...

250K€

Presupuesto del proyecto: 250K€

Líder del proyecto

INSTITUTO NEUROLOGICO MEDITERRANEO NEUROMED S... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-06-09 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INSTITUTO NEUROLOGICO MEDITE...

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Huntingtin hPSC Unraveling huntingtin function in cortical and striatal huma... 180K€ Cerrado

FUELING-TRANSPORT Deciphering the Role of Huntingtin in Energy Supply for Axon... 2M€ Cerrado

SAF2016-80573-R ALTERACIONES DE LA LAMINA NUCLEAR Y DE LA TRADUCCION PROTEIC... 182K€ Cerrado

SAF2012-39142 CDK5 COMO DIANA TERAPEUTICA PARA EL TRATAMIENTO DE LOS DEFII... 152K€ Cerrado

MitSyn Alpha synuclein and mitochondrial dysfunction key links bet... 183K€ Cerrado

SpecDroHuman Impact of α-spectrin mutations on the cytoskeleton and organ... 192K€ Cerrado

Líder del proyecto

INSTITUTO NEUROLOGICO MEDITERRANEO NEUROMED S... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 250K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Huntington’s disease (HD) is a neurodegenerative disorder caused by expansion of a CAG repeat, within the gene encoding huntingtin (Htt) and characterized by the progressive neurodegeneration and associated motor, cognitive and behavioral disturbances. Mutant Htt exerts adverse effects in neurons and non-neuronal cells. Animal studies describe white matter segmentation and myelin breakdown in HD. These evidences recapitulate the brain white matter volume loss described in pre-symptomatic and symptomatic subjects suggesting that white matter dysfunctions may represent a critical determinant in HD pathogenesis and may be identified as an early event of the disease. Recently, the applicant indentified a new dysfunctional pathway in HD, the dysregulation of ganglioside metabolism. High levels of gangliosides, in particular GM1, have been found to localize also in the myelin sheaths of oligodendrocytes where they play a crucial role in the maintenance of myelin integrity and in the regulation of axon–glia interactions. The applicant demonstrated that levels of GM1 are decreased in HD models and in fibroblasts from HD patients, contributing to heighten HD cells susceptibility to apoptosis. Importantly, administration of GM1 restored ganglioside levels and induced protective effects in HD models suggesting a therapeutic potential of GM1 in CNS. Our hypothesis is that decreased levels of GM1 may also affect white matter homeostasis. Interestingly, no studies correlating the dysregulation in gangliosides metabolism with white matter defects in HD have been conducted, so far. Thus, the main goal of this study is to look for white matter abnormalities and to determine the relationship with the degree of ganglioside dysfunctions and the severity of clinical status in HD. This will represent a new and interesting line of investigation in the field of HD and will provide more clear and deep understanding of the molecular mechanisms underlying the pathogenesis of the disease.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores